KOSDAQ · Healthcare · ₩659B
₩22,550-1.10%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 7.6% · as of 26.10.27
Among 37 신약 개발 peers
“신약 후보가 사람 대상 시험으로 넘어가 사업화 문턱에 섰어요.”
In the company's words · 2026 2분기 filing